Skip to content

Efficacy of Mindfulness-Based Stress Reduction on Reducing Somatization and Attachment Anxiety: A Randomized Controlled Trial

Jinghua Li, LuXin Zhou

Journal of Personality and Psychosomatic Research 2023 DOI: 10.61838/kman.jppr.1.4.3 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized controlled trial Peer reviewed
Sample size 30
Population Adults with symptoms of somatization and attachment anxiety
Intervention Mindfulness-Based Stress Reduction (MBSR)
Duration 12-week intervention with a two-month follow-up
Measures Patient Health Questionnaire-15 (PHQ-15), Experiences in Close Relationships-Revised (ECR-R)
Topics Anxiety Meditation
Key findings MBSR significantly reduced somatization (baseline mean 15.40 to 8.25 post-intervention and 9.10 at two-month follow-up) and attachment anxiety (18.60 to 12.70 post-intervention and 13.40 at follow-up) compared with a control group that showed no significant changes. The authors conclude that MBSR is effective for these conditions and support its integration into therapeutic practice.

Abstract

The objective of this study was to evaluate the effectiveness of Mindfulness-Based Stress Reduction (MBSR) in reducing symptoms of somatization and attachment anxiety in adults. This randomized controlled trial involved 30 participants, divided equally into an MBSR intervention group and a control group. Participants were assessed at baseline, post-intervention (12 weeks), and at a two-month follow-up using the Patient Health Questionnaire-15 (PHQ-15) and the Experiences in Close Relationships-Revised (ECR-R) questionnaire. Data were analyzed using Analysis of Variance (ANOVA) with repeated measures and Bonferroni post-hoc tests, employing SPSS version 27. The MBSR intervention group showed a significant reduction in somatization from a baseline mean of 15.40 (SD = 2.58) to 8.25 (SD = 1.93) post-intervention and 9.10 (SD = 2.05) at follow-up (p < .001). The control group showed no significant changes. Similarly, attachment anxiety in the intervention group decreased from a baseline mean of 18.60 (SD = 2.73) to 12.70 (SD = 2.35) post-intervention and 13.40 (SD = 2.48) at follow-up (p < .001), while the control group remained stable. The results demonstrate that MBSR is an effective intervention for reducing somatization and attachment anxiety. These findings support the integration of MBSR into therapeutic practices for individuals experiencing these conditions.

Comparable studies

Other randomized controlled trials on anxiety, most cited first.

Study Year Design Participants
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Cancer patients with life-threatening diagnoses and symptoms of depression and/or anxiety 2016 Randomized controlled trial n = 51
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Patients with cancer-related anxiety and depression 2016 Double-blind, placebo-controlled, crossover trial n = 29
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Hallucinogen-naïve adults reporting regular participation in religious or spiritual... 2006 Double-blind study n = 36
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer Adults with advanced-stage cancer and anxiety 2010 Double-blind, placebo-controlled study n = 12

Citations in the library

Explore topics